Celularity Inc cotiza a 1.42 USD y tiene una capitalización bursátil de $46M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Celularity Inc., a cellular and regenerative medicine company, focuses on addressing aging-related disease using novel therapies. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It develops off-the-shelf placental-derived allogeneic cell therapy product candidates, inclu…
| Periodo | 2025-08 | 2023-08 | 2023-05 | 2023-03 |
|---|---|---|---|---|
| Real | — | $-2.70 | $-4.10 | $-1.08 |
| Estimado | — | $-0.30 | $-2.40 | $-3.10 |
| Sorpresa | — | -800.0% | -70.8% | +65.2% |
| Métrica | CELU | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 24.4% | 57.0% | -32.6% |
| Operating Margin | -230.9% | -38.6% | -192.3% |
| Net Margin | -345.4% | -33.6% | -311.9% |
| FCF Margin | — | -13.9% | — |
| ROE | — | -40.4% | — |
| ROA | -85.5% | -32.0% | -53.4% |
| Current Ratio | 0.15 | 2.84 | -2.69 |
| Debt / Equity | -0.89 | 0.28 | -1.17 |